DVA vs EHC vs UHS
161 measures in 16 categories, one definition each, computed from filings and market data.
EHC64.4
Encompass Health Corporation
Healthcare · Medical - Care Facilities
$127.87 +0.10%$12.6B mkt cap
Score DNA
UHS61.1
Universal Health Services, Inc.
Healthcare · Medical - Care Facilities
$185.10 −1.18%$10.9B mkt cap
Score DNA
Price, rebased to 100 three years ago
DVA EHC UHS · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 0 | 1 |
| Last Congress purchase | 2026-03-27 | — | 2026-03-27 |
| 13F net change in holders | — | — | −56 |
| ETFs adding shares, 30d | 537 | 332 | 455 |
| ETFs trimming, 30d | 381 | 262 | 501 |
| Net ETF funds, 30d | +156 | +70 | −46 |
Valuation
16 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| P/E (TTM) | 14.1x
30th
|
20.3x
43rd
|
7.1x
4th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.38
23rd
|
0.78
46th
|
0.19
8th
|
| Price / sales | 0.9x
34th
|
2.0x
81st
|
0.6x
19th
|
| Price / book | — | 4.9x
71st
|
1.5x
14th
|
| Price / tangible book | — | 10.4x
69th
|
2.5x
0th
|
| Price / free cash flow | 7.4x
15th
|
30.5x
85th
|
13.2x
37th
|
| Price / operating cash flow | 5.4x
17th
|
10.4x
45th
|
6.1x
24th
|
| Enterprise value | $22.0B
94th
|
$15.3B
88th
|
$16.0B
91st
|
| EV / sales | 1.6x
50th
|
2.5x
84th
|
0.9x
19th
|
| EV / EBITDA | 8.0x
25th
|
10.2x
46th
|
5.7x
7th
|
| EV / EBIT | 10.7x
30th
|
13.3x
37th
|
7.4x
7th
|
| EV / free cash flow | 13.7x
26th
|
37.1x
89th
|
19.4x
41st
|
| Earnings yield | 7.1%
78th
|
4.9%
69th
|
14.0%
97th
|
| FCF yield | 13.5%
88th
|
3.3%
28th
|
7.6%
69th
|
| Operating cash flow yield | 18.4%
84th
|
9.6%
59th
|
16.5%
78th
|
| Graham number (per share) | — | $60.25
67th
|
$267.97
100th
|
Profitability (TTM)
12 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Gross margin | 31.0%
66th
|
43.9%
84th
|
90.7%
100th
|
| EBITDA margin | 19.7%
78th
|
24.2%
94th
|
15.6%
69th
|
| Operating margin | 15.1%
84th
|
18.0%
94th
|
11.4%
72nd
|
| EBIT margin | 14.7%
78th
|
18.6%
88th
|
12.0%
66th
|
| Net margin | 6.0%
56th
|
10.0%
84th
|
8.4%
69th
|
| NOPAT margin | 11.9%
81st
|
14.3%
91st
|
8.7%
69th
|
| FCF margin | 11.5%
78th
|
6.7%
50th
|
4.6%
28th
|
| Operating cash flow margin | 15.7%
88th
|
19.5%
94th
|
9.9%
47th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 12.4%
41st
|
17.3%
59th
|
46.7%
91st
|
| Stock comp / revenue | 0.9%
60th
|
0.9%
53rd
|
0.3%
17th
|
| Effective tax rate | 20.7%
23rd
|
20.5%
19th
|
23.5%
61st
|
Returns on capital
11 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| ROE (on average equity) | — | 25.5%
76th
|
21.0%
69th
|
| ROA | 4.8%
44th
|
8.7%
72nd
|
9.9%
78th
|
| ROIC | 17.9%
75th
|
16.7%
72nd
|
12.5%
59th
|
| ROCE | 13.8%
56th
|
17.5%
81st
|
17.2%
78th
|
| Return on tangible assets | 11.7%
56th
|
16.2%
81st
|
14.1%
75th
|
| Cash ROIC (OCF / invested capital) | 23.5%
66th
|
22.7%
62nd
|
14.2%
44th
|
| Gross profitability (GP / assets) | 24.5%
47th
|
49.0%
84th
|
103.1%
97th
|
| ROIC, 3-yr average | 9.8%
75th
|
10.6%
82nd
|
9.2%
71st
|
| ROIC, 5-yr average | — | 9.9%
83rd
|
9.5%
78th
|
| ROE, 5-yr average | — | 21.2%
91st
|
15.5%
82nd
|
| Incremental ROIC | -41.6%
13th
|
99.7%
58th
|
82.7%
55th
|
Growth
17 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Revenue growth (TTM YoY) | 6.4%
34th
|
9.5%
47th
|
10.0%
50th
|
| Revenue growth (QoQ) | 4.1%
53rd
|
0.7%
16th
|
3.2%
34th
|
| Revenue CAGR, 3 yr | 6.1%
21st
|
10.7%
46th
|
9.5%
36th
|
| Revenue CAGR, 5 yr | 3.9%
19th
|
4.8%
27th
|
8.2%
35th
|
| Gross profit CAGR, 3 yr | 8.0%
36th
|
5.6%
28th
|
10.2%
44th
|
| Operating income CAGR, 3 yr | 18.0%
68th
|
-1.7%
16th
|
23.4%
74th
|
| Net income growth (TTM YoY) | 1.3%
17th
|
18.8%
39th
|
21.0%
50th
|
| Net income CAGR, 3 yr | 21.9%
47th
|
25.5%
67th
|
30.2%
73rd
|
| EPS growth (TTM YoY) | 18.6%
33rd
|
21.4%
39th
|
31.2%
56th
|
| EPS CAGR, 3 yr | 36.8%
73rd
|
26.0%
60th
|
37.6%
80th
|
| EPS CAGR, 5 yr | 10.6%
43rd
|
10.1%
36th
|
15.1%
57th
|
| FCF growth (TTM YoY) | 24.9%
38th
|
-5.9%
19th
|
-8.3%
15th
|
| FCF CAGR, 3 yr | 5.9%
24th
|
53.7%
88th
|
17.5%
41st
|
| Operating cash flow CAGR, 3 yr | 3.7%
17th
|
21.4%
52nd
|
15.4%
39th
|
| Book value CAGR, 3 yr | — | 21.2%
82nd
|
13.4%
68th
|
| Dividend CAGR, 3 yr | — | 4.3%
67th
|
3.6%
56th
|
| Sustainable growth rate | — | 22.4%
62nd
|
20.3%
52nd
|
Margin history & stability
7 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Gross margin, 3-yr average | 32.1%
59th
|
47.5%
86th
|
90.1%
100th
|
| Operating margin, 3-yr average | 15.3%
90th
|
20.2%
97th
|
10.7%
72nd
|
| Net margin, 3-yr average | 6.4%
72nd
|
9.0%
93rd
|
7.4%
83rd
|
| FCF margin, 3-yr average | 10.5%
93rd
|
6.2%
59th
|
5.2%
45th
|
| Revenue stability (0-1) | 0.88
38th
|
0.66
14th
|
0.97
83rd
|
| Earnings stability (0-1) | 0.01
10th
|
0.68
83rd
|
0.45
72nd
|
| Margin stability (0-1) | 0.96
83rd
|
0.64
14th
|
0.99
100th
|
Liquidity (latest quarter)
7 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Cash & short-term investments | $688.9M
88th
|
$107.7M
28th
|
$138.8M
31st
|
| Net cash (− = net debt) | −$10.1B
6th
|
−$2.7B
22nd
|
−$5.1B
12th
|
| Working capital | $1.3B
97th
|
$167.6M
59th
|
$381.7M
78th
|
| Current ratio | 1.47
69th
|
1.19
38th
|
1.12
22nd
|
| Quick ratio | 1.41
75th
|
1.19
41st
|
1.04
22nd
|
| Cash ratio (cash + ST investments / current liabilities) | 0.24
38th
|
0.12
12th
|
0.04
0th
|
| Defensive interval (days) | 607 days
68th
|
114 days
10th
|
75 days
3rd
|
Leverage & solvency (latest quarter)
13 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Total debt | $10.8B
94th
|
$2.8B
78th
|
$5.3B
88th
|
| Debt / equity | — | 1.09
61st
|
0.70
36th
|
| Net debt / equity | — | 1.05
64th
|
0.68
46th
|
| Debt / assets | 60.9%
84th
|
38.1%
53rd
|
33.0%
44th
|
| Debt / capital | — | 52.2%
61st
|
41.2%
36th
|
| Debt / EBITDA | 3.90
71st
|
1.89
32nd
|
1.87
29th
|
| Net debt / EBITDA | 3.65
75th
|
1.82
43rd
|
1.82
39th
|
| Interest coverage (EBIT / interest) | 3.7x
33rd
|
9.2x
63rd
|
13.9x
70th
|
| Cash interest coverage | 3.9x
33rd
|
9.7x
50th
|
11.5x
57th
|
| Debt payback (years of OCF) | 4.9 yrs
66th
|
2.3 yrs
34th
|
2.9 yrs
41st
|
| Liabilities / assets | 93.9%
91st
|
53.6%
38th
|
52.0%
34th
|
| IS credit model rating | BB | A | A |
| Implied credit spread (bps) | 475
78th
|
150
31st
|
150
31st
|
Efficiency
11 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Asset turnover | 0.80
25th
|
0.87
31st
|
1.17
56th
|
| Fixed asset turnover | 2.70
32nd
|
1.37
16th
|
2.41
23rd
|
| Inventory turnover | 64.9
67th
|
— | 7.4
0th
|
| Receivables turnover | 5.7
9th
|
9.5
56th
|
7.1
19th
|
| Days sales outstanding | 64 days
91st
|
38 days
44th
|
51 days
81st
|
| Days inventory outstanding | 6 days
38th
|
— | 49 days
100th
|
| Days payables outstanding | 25 days
53rd
|
28 days
56th
|
503 days
100th
|
| Cash conversion cycle (days) | 45 days
91st
|
10 days
22nd
|
−402 days
0th
|
| Capex / revenue | 4.2%
68th
|
12.9%
100th
|
5.4%
77th
|
| Capex / depreciation | 0.82
48th
|
2.31
94th
|
1.52
84th
|
| Operating expense ratio | 16.6%
53rd
|
26.5%
72nd
|
79.7%
100th
|
Cash flow & earnings quality
7 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Operating cash flow / net income | 2.59
78th
|
1.95
70th
|
1.18
9th
|
| FCF / net income | 1.90
78th
|
0.67
13th
|
0.54
4th
|
| FCF / operating cash flow | 73.4%
46th
|
34.1%
14th
|
45.9%
18th
|
| Capex / operating cash flow | 26.6%
54th
|
65.9%
86th
|
54.1%
82nd
|
| Accruals ratio | -7.6%
34th
|
-8.3%
25th
|
-1.8%
94th
|
| Sloan accruals ratio | -3.0%
50th
|
-3.3%
44th
|
-6.0%
28th
|
| Earnings quality score (0-1) | 0.75
9th
|
0.75
9th
|
1.00
65th
|
Scores & forensic checks
15 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| IS score | 44
31st
|
64
72nd
|
61
59th
|
| IS profitability | 30
41st
|
61
94th
|
60
91st
|
| IS growth | 56
25th
|
61
38th
|
63
47th
|
| IS value | 51
62nd
|
57
66th
|
88
100th
|
| IS momentum | 75
38th
|
87
56th
|
86
53rd
|
| IS risk (safety) | 30
12th
|
80
56th
|
65
44th
|
| IS quality | 64
59th
|
80
88th
|
79
84th
|
| IS balance sheet | 27
16th
|
55
56th
|
61
66th
|
| IS earnings quality | 63
34th
|
72
50th
|
79
81st
|
| IS cash flow | 64
62nd
|
45
38th
|
40
28th
|
| Piotroski F-score (0-9) | 8
78th
|
9
97th
|
8
78th
|
| Altman Z-score | 1.8
16th
|
3.2
62nd
|
3.0
53rd
|
| Beneish M-score | −2.81
28th
|
−2.75
31st
|
−2.37
69th
|
| Ohlson O-score | −5.68
84th
|
−8.11
31st
|
−8.39
22nd
|
| IS credit score | 44
22nd
|
72
62nd
|
71
59th
|
Size (TTM)
8 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| Market cap | $12.0B
91st
|
$12.6B
94th
|
$10.9B
88th
|
| Revenue | $14.0B
88th
|
$6.2B
81st
|
$18.1B
91st
|
| EBITDA | $2.8B
88th
|
$1.5B
84th
|
$2.8B
91st
|
| Net income | $847.5M
91st
|
$621.0M
88th
|
$1.5B
94th
|
| Free cash flow | $1.6B
94th
|
$413.4M
81st
|
$826.7M
91st
|
| Total assets | $17.7B
94th
|
$7.5B
81st
|
$15.9B
91st
|
| Shareholders' equity | −$765.1M
6th
|
$2.6B
94th
|
$7.5B
100th
|
| Employees | 78,000
91st
|
29,699
66th
|
101,500
97th
|
Price performance
9 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| 1 day | −1.0% | +0.1% | −1.2% |
| 1 week | +4.5% | +3.7% | +4.4% |
| 1 month | +2.3% | +4.0% | +2.4% |
| 3 months | −20.0% | +13.7% | +22.9% |
| 6 months | +26.6% | +20.2% | +1.5% |
| Year to date | +63.6% | +20.2% | −15.7% |
| 1 year | +48.7% | +3.4% | −9.6% |
| 3 years, cumulative | +146.8% | +101.9% | +47.2% |
| 5 years, cumulative | +65.4% | +135.9% | +45.1% |
Technicals
4 measures| Measure | DVA | EHC | UHS |
|---|---|---|---|
| RSI 14 | 57.6 | 66.3 | 63.5 |
| From 52-week high | −24.3% | −1.6% | −24.8% |
| From 52-week low | +85.5% | +37.9% | +32.2% |
| Beta | 0.80 | 0.61 | 1.03 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17